Global Wearable Injectors Market By Type (Body-Worn Patch Injector, Off-Body Worn Belt Injector and Bolus Injector), By Technology (Electronic Injector, Mechanical Injector and Others), By Application (Cancer, Infectious Disease, Autoimmune Disorder, Cardiovascular Disease, Blood Disorder and Others), By End User (Home Care, Hospital, Lab & Diagnostics and Others)

Global Wearable Injectors Market By Type (Body-Worn Patch Injector, Off-Body Worn Belt Injector and Bolus Injector), By Technology (Electronic Injector, Mechanical Injector and Others), By Application (Cancer, Infectious Disease, Autoimmune Disorder, Cardiovascular Disease, Blood Disorder and Others), By End User (Home Care, Hospital, Lab & Diagnostics and Others)

Published: 21/11/2018

Report Code: BWC1841

Available Format: PDF PDF Icon

Pages: 200

Global Wearable Injectors Market: Overview

Global Wearable Injectors market report provides analysis for the period 2012–2024. The market study reveals that the Global Wearable Injectors market is projected to rise over a CAGR of 24.53% during 2018-2024 in terms of value. This growth is driven by rising usage of advance drug delivery devices at home. Rise in prevalence of chronic diseases among old age population is surging the demand for wearable injector’s products over the projected timeframe.

The market overview section of the report demonstrates market dynamics such as, drivers and restraints that talks about the current nature and future scenario of the said market, key market indicators and raw material analysis. End-user segment comprises of homecare, hospital, lab & diagnostics, other. Further, key market indicators included in the report provide the significant factors which are capable to define the market position of Global Wearable Injectors Market. Furthermore, various analysis methods like Porter’s, Pestle are also included in the report to provide an in-depth view of the market scenario.

Global Wearable Injectors Market: Scope of the Report

On the basis of the type of product, body-worn patch injector devices hold 46.92% market share of global wearable injectors market. Off-Body Worn Belt Injector and Bolus Injector type devices will grow with a CAGR of 5.78% and 42.36% in term of value, respectively. North America is leading the global wearable injectors market with a CAGR of 24.48%, in terms of value. Electronic injectors is likely to surpass USD 7,861.5 million by 2024 owing shift in usage of self-administrative injectable devices and availability at economic prices.  Finally, the report covers the analysis of these segments across North America, Europe, Asia Pacific, Middle East & Africa and Latin America along with the qualitative analysis for market estimates that boosts the growth of the global wearable injectors market during the forecast period.

The report also highlights the competitive landscape of the Global Wearable Injectors market that includes the company overview, products & offerings, strategic decisions taken by the company, launch of new products, technology landscape, and financial highlights.

Global Wearable Injectors Market: Key Stakeholders

  • Becton, Dickinson, and Company
  • Medtronic plc
  • Johnson & Johnson
  • F. Hoffmann-La Roche Lt

Global Wearable Injectors Market, Revenue Forecast, USD (Million), 2018-2024

Wearable Injectors Market
Source: BlueWeave Consulting & Research Pvt Ltd.

Global Wearable Injectors Market: Key Findings of the Report

According to BlueWeave Consulting, the key findings of the report “Global Wearable Injectors Market Product, Technology, End-user, Application, Growth and Demand Forecast to 2024” are:

  • The demand for Global Wearable Injectors market is expected to grow at a significant rate, during forecast period. Wearable Injectors is witnessing tremendous growth owing to increasing life expectancy and fall in birth rates increasing old age population. The elderly population requires extensive care, as they are prone to illness due to low immunity levels and high recovery time. The elderly people are more susceptible to chronic diseases, such as cancer, diabetes, neurological disorders and cardiovascular diseases, thus increasing the usage of wearable injectors across the globe.
  • Body-worn patch injectors are the largest contributor, in terms of value, as compared to Off-body worn belt injectors. It is expected to rise with CAGR over 5.8% by value during the forecast period, 2012-2024.
  • Global Wearable Injectors market for technology segment is estimated to rise with a CAGR over 20.69% during the period of 2018-2024 with electronic injectors being the highest revenue generator, with market share of 54.76%.
  • North America is the fastest growing region in the Wearable Injectors market and is expected to propel with a CAGR over 24.48% by value during the forecast period, 2018-2024 with Japan being the fastest growing market having a CAGR over 21.9% and expected to reach revenue of around USD 1,170.4 million by the end of 2024.

Global Wearable Injectors Market: Research Methodology

Extensive secondary research was conducted using paid data sources including Bloomberg, Factiva, Capital IQ, OneSource, and Hoovers. Additionally, several publicly-available data sources were used including journals, statistics articles, and industry associations. These data sources were used to gather relevant information to develop an understanding on the global Wearable Injectors market. The research was conducted covering the desk research and primary research. Data sources used for primary research included online forums and blogs, CATI/CAWI, CAPI interviews, and video conferences. Additionally, interviews were conducted through connecting with various industry respondents including C-level executives, directors, divisional heads, regional heads, expert consultants, and independent consultants. The primary research was conducted to gain market insights from industry respondents and validate the gathered information through desk research.

Global Wearable Injectors Market: Competitive Dynamics

The Global Wearable Injectors market is dominated by a number of players, amongst them the major players are Becton, Dickinson and Company, Medtronic plc, Johnson & Johnson, nilife Corporation, CeQur SA, etc. Companies in this industry are following different strategies to strengthen their market position.

Chapter 1.         Research Methodology

1.1            Market Definition

1.2            Research Scope

1.2.1            Global wearable injector market, by type

1.2.2            Global wearable injector market, by technology

1.2.3            Global wearable injector market, by application

1.2.4            Global wearable injector market, by end user

1.2.5            Global wearable injector market, by geography

1.3            Research Approach and Sources

Chapter 2.         Executive Summary

2.1            Key Findings

2.2            Research Summary

Chapter 3.         Market Outlook

3.1            Introduction

3.2            Global Wearable Injectors Market Opportunities

3.2.1            High usage of wearable injectors in emerging markets

3.3            Factors Driving the Growth of the Market and its Impact on Market Forecast

3.3.1            Ageing population

3.3.2            Accelerating pervasiveness of chronic diseases

3.3.3            Growing demand for advance drug delivery

3.3.4            Rise in pipeline for biologic drugs

3.3.5            Market analysis of drivers over forecast period

3.4            Restraning Factors hindering market growth

3.4.1            Alternative drug delivery methods

3.4.2            Disadvantage of wearable injector

3.4.3            Market challenges analysis on market forecast

Chapter 4.         Global Wearable Injectors Market Size and Forecast (2012 – 2024)

4.1            Global Wearable Injectors Market, by Type

4.2            Global Wearable Injectors Market, by Technology

4.3            Global Wearable Injectors Market, by Application

4.4            Global Wearable Injectors Market, by End User

4.5            Global Wearable Injectors Market, by Region

Chapter 5.         Global Wearable Injectors Market, by Type

5.1            Body-Worn Patch Injector Market

5.1.1            Global body-worn patch injector market, by region

5.2            Off-Body Worn Belt Injector Market

5.2.1            Global off-body worn belt injector market, by region

5.3            Bolus Injector Market

5.3.1            Global bolus injector market, by region

Chapter 6.         Global Wearable Injectors Market, by Technology

6.1            Electronic Wearable Injector Market

6.1.1            Global electronic wearable injector market, by region

6.2            Mechanical Wearable Injector Market

6.2.1            Global mechanical wearable injectors market, by region

Chapter 7.         Global Wearable Injectors Market, by Application

7.1            Wearable Injector Market for Cancer

7.1.1            Global wearable injector market for cancer, by region

7.2            Wearable Injector Market for Infectious Disease

7.2.1            Global wearable injector market for infectious disease, by region

7.3            Wearable Injector Market for Autoimmune Disorder

7.3.1            Global wearable injectors for autoimmune disorder, by region

7.4            Wearable Injectors Market for Cardiovascular Disease

7.4.1            Global wearable injector market for cardiovascular disese, by region

7.5            Wearable Injectors Market for Blood Disorder

7.6            Global wearable injector for blood disorder, by region

Chapter 8.         Global Wearable Injectors Market, by End User

8.1            Wearable Injector Market in Homecare

8.2            Global wearable injector market in homecare, by region

8.3            Wearable Injector Market in Hospital

8.4            Global wearable injector market in hospital, by region

8.5            Wearable Injector Market in Lab & Diagnostics

8.6            Global wearable injector market in lab & diagnostics, by region

Chapter 9.         Global Wearable Injectors Market, by Geography

9.1            North America Wearable Injector Market

9.1.1            North America wearable injector market, by type

9.1.2            North America wearable injector market, by technology

9.1.3            North America wearable injectors market, by application

9.1.4            North America wearable injector market, by end user

9.1.5            North America wearable injector market, by country

9.2            Latin America Wearable Injector Market

9.2.1            Latin America wearable injectors market, by type

9.2.2            Latin America wearable injector market, by technology

9.2.3            Latin America wearable injector market, by application

9.2.4            Latin America wearable injector market, by end user

9.2.5            Latin America wearable injector market, by country

9.3            Europe Wearable Injector Market

9.3.1            Europe wearable injector market, by type

9.3.2            Europe wearable injector market, by technology

9.3.3            Europe wearable injector market, by application

9.3.4            Europe wearable injector market, by end user

9.3.5            Europe wearable injector market, by country

9.4            APAC Wearable Injector Market

9.4.1            APAC wearable injector market, by type

9.4.2            APAC wearable injector market, by technology

9.4.3            APAC wearable injector market, by application

9.4.4            APAC wearable injector market, by end user

9.4.5            APAC wearable injector market, by country

9.5            MEA Wearable Injector Market

9.5.1            MEA wearable injector market, by type

9.5.2            MEA wearable injector market, by technology

9.5.3            MEA wearable injector market, by application

9.5.4            MEA wearable injector market, by end user

Chapter 10.     Competitive Landscape

10.1         Porters Five Forces of Competitive Position Analysis

10.1.1         Bargaining power of buyers

10.1.2         Bargaining power of suppliers

10.1.3         Threat of new entrants

10.1.4         Intensity of rivalry

10.1.5         Threat of substitutes

10.2         Competitive Positioning of the Global Wearable Injectors Market, by Type

10.3         Competitive Benchmarking Of the Key Players in the Global Wearable Injectors Market, by Type

10.4         Market Share Analysis of the Global Wearable Injectors Market

10.5         Company Profiles

10.5.1         Becton, Dickinson and Company

10.5.1.1      Business overview

10.5.1.2      Product and service offerings

10.5.2         Medtronic plc

10.5.2.1      Business overview

10.5.2.2      Product and service offerings

10.5.3         Johnson & Johnson

10.5.3.1      Business overview

10.5.3.2      Product and service offerings

10.5.4         F. Hoffmann-La Roche Ltd.

10.5.4.1      Business overview

10.5.4.2      Product and service offerings

10.5.5         Unilife Corporation

10.5.5.1      Business overview

10.5.5.2      Product and service offerings

10.5.6         CeQur SA

10.5.6.1      Business overview

10.5.6.2      Product and service offerings

10.5.7         Sensile Medical AG

10.5.7.1      Business overview

10.5.7.2      Product and service offerings

10.5.8         Enable Injections

10.5.8.1      Business overview

10.5.8.2      Product and service offerings

10.5.9         ScPharmaceuticals, Inc.

10.5.9.1      Business overview

10.5.9.2      Product and service offerings

10.5.10      SteadyMed Ltd.

10.5.10.1   Business overview

10.5.10.2   Product and service offerings

10.5.11      Insulet Corporation

10.5.11.1   Business overview

10.5.11.2   Product and service offerings

10.5.12      Ypsomed Group

10.5.12.1   Business overview

10.5.12.2   Product and service offerings

10.5.13      West Pharmaceutical Services, Inc.

10.5.13.1   Business overview

10.5.13.2   Product and service offerings

10.5.14      Bühler Motor GmbH

10.5.14.1   Business overview

10.5.14.2   Product and service offerings

10.5.15      Canè S.p.A.

10.5.15.1   Business overview

10.5.15.2   Product and service offerings

10.6         Strategic Developments in the Global Wearable Injectors Market

10.7      List of Abbreviations 102

List of Table

TABLE 1:       SPECIFIC PRIMARY AND SECONDARY SOURCES USED FOR THIS PUBLICATION

TABLE 2:       GLOBAL WEARABLE INJECTORS MARKET SNAPSHOT

TABLE 3:       NUMBER OF WORLDWIDE DEATHS DUE TO VARIOUS DISEASES

TABLE 4:       DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 5:       RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 6:       GLOBAL WEARABLE INJECTORS MARKET, BY TYPE, $M (2012 – 2017)

TABLE 7:       GLOBAL WEARABLE INJECTORS MARKET, BY TYPE, $M (2018 – 2024)

TABLE 8:       GLOBAL WEARABLE INJECTORS MARKET, BY TECHNOLOGY, $M (2012 – 2017)

TABLE 9:       GLOBAL WEARABLE INJECTORS MARKET, BY TECHNOLOGY, $M (2018 – 2024)

TABLE 10:      GLOBAL WEARABLE INJECTORS MARKET, BY APPLICATION, $M (2012 – 2017)

TABLE 11:      GLOBAL WEARABLE INJECTORS MARKET, BY APPLICATION, $M (2018 – 2024)

TABLE 12:      GLOBAL WEARABLE INJECTORS MARKET, BY END USER, $M (2012 – 2024)

TABLE 13:      GLOBAL WEARABLE INJECTORS MARKET, BY END USER, $M (2018 – 2024)

TABLE 14:      GLOBAL WEARABLE INJECTORS MARKET, BY REGION, $M (2012 – 2017)

TABLE 15:      GLOBAL WEARABLE INJECTORS MARKET, BY REGION, $M (2017 – 2024)

TABLE 16:      NORTH AMERICA WEARABLE INJECTOR MARKET, BY TYPE, $M (2012 – 2017)

TABLE 17:      NORTH AMERICA WEARABLE INJECTOR MARKET, BY TYPE, $M (2018 – 2024)

TABLE 18:      NORTH AMERICA WEARABLE INJECTOR MARKET, BY TECHNOLOGY, $M (2012 – 2017)

TABLE 19:      NORTH AMERICA WEARABLE INJECTOR MARKET, BY TECHNOLOGY, $M (2018 – 2024)

TABLE 20:      NORTH AMERICA WEARABLE INJECTOR MARKET, BY APPLICATION, $M (2012 – 2017)

TABLE 21:      NORTH AMERICA WEARABLE INJECTOR MARKET, BY APPLICATION, $M (2018– 2024)

TABLE 22:      NORTH AMERICA WEARABLE INJECTOR MARKET, BY END USER, $M (2012 – 2015)

TABLE 23:      NORTH AMERICA WEARABLE INJECTOR MARKET, BY END USER, $M (2018 – 2024)

TABLE 24:      NORTH AMERICA WEARABLE INJECTOR MARKET, BY COUNTRY, $M (2012 – 2017)

TABLE 25:      NORTH AMERICA WEARABLE INJECTOR MARKET, BY COUNTRY, $M (2018 – 2024)

TABLE 26:      LATIN AMERICA WEARABLE INJECTOR MARKET, BY TYPE, $M (2012 – 2017)

TABLE 27:          LATIN AMERICA WEARABLE INJECTOR MARKET, BY TYPE, $M (2018 – 2024)

TABLE 28:      LATIN AMERICA WEARABLE INJECTOR MARKET, BY TECHNOLOGY, $M (2012 – 2017)

TABLE 29:      LATIN AMERICA WEARABLE INJECTOR MARKET, BY TECHNOLOGY, $M (2018 – 2024)

TABLE 30:      LATIN AMERICA WEARABLE INJECTOR MARKET, BY APPLICATION, $M (2012 – 2017)

TABLE 31:      LATIN AMERICA WEARABLE INJECTOR MARKET, BY APPLICATION, $M (2018 – 2024)

TABLE 32:      LATIN AMERICA WEARABLE INJECTOR MARKET, BY END USER, $M (2012 – 2017)

TABLE 33:      LATIN AMERICA WEARABLE INJECTOR MARKET, BY END USER, $M (2018 – 2024)

TABLE 34:      LATIN AMERICA WEARABLE INJECTOR MARKET, BY COUNTRY, $M (2012 – 2017)

TABLE 35:      LATIN AMERICA WEARABLE INJECTOR MARKET, BY COUNTRY, $M (2018 – 2024)

TABLE 36:      EUROPE WEARABLE INJECTOR MARKET, BY TYPE, $M (2012 – 2017)

TABLE 37:      EUROPE WEARABLE INJECTOR MARKET, BY TYPE, $M (2018 – 2024)

TABLE 38:      EUROPE WEARABLE INJECTOR MARKET, BY TECHNOLOGY, $M (2012 – 2017)

TABLE 39:      EUROPE WEARABLE INJECTOR MARKET, BY TECHNOLOGY, $M (2018 – 2024)

TABLE 40:      EUROPE WEARABLE INJECTOR MARKET, BY APPLICATION, $M (2012 – 2017)

TABLE 41:      EUROPE WEARABLE INJECTOR MARKET, BY APPLICATION, $M (2018 – 2024)

TABLE 42:      EUROPE WEARABLE INJECTOR MARKET, BY END USER, $M (2012 – 2017)

TABLE 43:      EUROPE WEARABLE INJECTOR MARKET, BY END USER, $M (2018 – 2024)

TABLE 44:      EUROPE WEARABLE INJECTOR MARKET, BY COUNTRY, $M (2012 – 2017)

TABLE 45:      EUROPE WEARABLE INJECTOR MARKET, BY COUNTRY, $M (2018 – 2024)

TABLE 46:      APAC WEARABLE INJECTOR MARKET, BY TYPE, $M (2012 – 2017)

TABLE 47:      APAC WEARABLE INJECTOR MARKET, BY TYPE, $M (2018 – 2024)         64

TABLE 48:      APAC WEARABLE INJECTOR MARKET, BY TECHNOLOGY, $M (2012 – 2017)

TABLE 49:      APAC WEARABLE INJECTOR MARKET, BY TECHNOLOGY, $M (2018 – 2024)

TABLE 50:      APAC WEARABLE INJECTOR MARKET, BY APPLICATION, $M (2012 – 2017)

TABLE 51:      APAC WEARABLE INJECTOR MARKET, BY APPLICATION, $M (2018 – 2024)

TABLE 52:      APAC WEARABLE INJECTOR MARKET, BY END USER, $M (2012 – 2015)

TABLE 53:      APAC WEARABLE INJECTOR MARKET, BY END USER, $M (2018 – 2024)

TABLE 54:      APAC WEARABLE INJECTOR MARKET, BY COUNTRY, $M (2012 – 2017)

TABLE 55:      APAC WEARABLE INJECTOR MARKET, BY COUNTRY, $M (2018 – 2024)

TABLE 56:      MEA WEARABLE INJECTOR MARKET, BY TYPE, $M (2012 – 2015)

TABLE 57:      MEA WEARABLE INJECTOR MARKET, BY TYPE, $M (2016 – 2024)

TABLE 58:      MEA WEARABLE INJECTOR MARKET, BY TECHNOLOGY, $M (2012 – 2015)

TABLE 59:      MEA WEARABLE INJECTOR MARKET, BY TECHNOLOGY, $M (2016 – 2024)

TABLE 60:      MEA WEARABLE INJECTOR MARKET, BY APPLICATION, $M (2012 – 2017)

TABLE 61:      MEA WEARABLE INJECTOR MARKET, BY APPLICATION, $M (2018 – 2024)

TABLE 62:      MEA WEARABLE INJECTOR MARKET, BY END USER, $M (2012 – 2017)

TABLE 63:      MEA WEARABLE INJECTOR MARKET, BY END USER, $M (2016 – 2024)

TABLE 64:      BECTON, DICKINSON AND COMPANY – KEY FACTS

TABLE 65:      MEDTRONIC PLC– KEY FACTS

TABLE 66:      JOHNSON & JOHNSON – KEY FACTS

TABLE 67:      F. HOFFMANN-LA ROCHE LTD.– KEY FACTS

TABLE 68:      UNILIFE CORPORATION – KEY FACTS

TABLE 69:      CEQUR SA – KEY FACTS

TABLE 70:      SENSILE MEDICAL AG – KEY FACTS

TABLE 71:      ENABLE INJECTIONS – KEY FACTS

TABLE 72:      SCPHARMACEUTICALS INC.– KEY FACTS

TABLE 73:      STEADYMED LTD. – KEY FACTS

TABLE 74:      INSULET CORPORATION – KEY FACTS

TABLE 75:      YPSOMED GROUP – KEY FACTS

TABLE 76:      WEST PHARMACEUTICAL SERVICES, INC. – KEY FACTS

TABLE 77:      BÜHLER MOTOR GMBH – KEY FACTS

TABLE 78:      CANÈ S.P.A.– KEY FACTS

List of Figures

FIG 1: RESEARCH SCOPE FOR GLOBAL WEARABLE INJECTORS MARKET

FIG 2: RESEARCH METHODOLOGY FOR GLOBAL WEARABLE INJECTORS MARKET

FIG 3: WEARABLE INJECTORS

FIG 4: AGING POPULATION AS A PERCENTAGE OF TOTAL POPULATION

FIG 5: GLOBAL INCIDENCE OF CANCER (EXCL. NON-MELANOMA SKIN CANCER) (2015)

FIG 6: GLOBAL DIABETIC POPULATION, AGED 20-79 YEARS (2013)

FIG 7: GLOBAL WEARABLE INJECTORS MARKET, $M (2012 – 2024)

FIG 8: GLOBAL WEARABLE INJECTORS MARKET SPLIT, BY TYPE (2017)

FIG 9: GLOBAL WEARABLE INJECTORS MARKET SPLIT, BY END USER (2017)

FIG 10: GLOBAL WERARABLE INJECTORS MARKET, BY REGION (2017)

FIG 11: GLOBAL WEARABLE INJECTOR MARKET FOR CANCER SPLIT, BY REGION (2017)

FIG 12: GLOBAL WEARABLE INJECTOR MARKET FOR INFECTIOUS DISEASE SPLIT, BY REGION (2017)

FIG 13: GLOBAL WEARABLE INJECTOR MARKET FOR AUTOIMMUNE DISORDER SPLIT, BY REGION (2017)

FIG 14: GLOBAL WEARABLE INJECTOR FOR CARDIOVASCULAR DISEASE MARKET SPLIT, BY REGION (2017)

FIG 1: RESEARCH SCOPE FOR GLOBAL WEARABLE INJECTORS MARKET

FIG 2: RESEARCH METHODOLOGY FOR GLOBAL WEARABLE INJECTORS MARKET

FIG 3: WEARABLE INJECTORS

FIG 4: AGING POPULATION AS A PERCENTAGE OF TOTAL POPULATION

FIG 5: GLOBAL INCIDENCE OF CANCER (EXCL. NON-MELANOMA SKIN CANCER) (2015)

FIG 6: GLOBAL DIABETIC POPULATION, AGED 20-79 YEARS (2013)

FIG 7: GLOBAL WEARABLE INJECTORS MARKET, $M (2012 – 2024)

FIG 8: GLOBAL WEARABLE INJECTORS MARKET SPLIT, BY TYPE (2017)

FIG 9: GLOBAL WEARABLE INJECTORS MARKET SPLIT, BY END USER (2017)

FIG 10: GLOBAL WERARABLE INJECTORS MARKET, BY REGION (2017)

FIG 11: GLOBAL WEARABLE INJECTOR MARKET FOR CANCER SPLIT, BY REGION (2017)

FIG 12: GLOBAL WEARABLE INJECTOR MARKET FOR INFECTIOUS DISEASE SPLIT, BY REGION (2017)

FIG 13: GLOBAL WEARABLE INJECTOR MARKET FOR AUTOIMMUNE DISORDER SPLIT, BY REGION (2017)

FIG 14: GLOBAL WEARABLE INJECTOR FOR CARDIOVASCULAR DISEASE MARKET SPLIT, BY REGION (2017)

FIG 15: GLOBAL WEARABLE INJECTOR MARKET FOR BLOOD DISORDER SPLIT, BY REGION (2017)

FIG 16: GLOBAL WEARABLE INJECTOR MARKET IN HOSPITAL SPLIT, BY REGION (2017)

FIG 17: GLOBAL WEARABLE INJECTOR MARKET IN LAB & DIAGNOSTIC CENETER SPLIT, BY REGION (2017)

FIG 18: NORTH AMERICA WEARABLE INJECTOR MARKET SPLIT, BY TYPE (2017)

FIG 19: NORTH AMERICA WEARABLE INJECTOR MARKET SPLIT, BY END USER (2017)

FIG 20: NORTH AMERICA WEARABLE INJECTOR MARKET SPLIT, BY COUNTRY (2017)

FIG 21: LATIN AMERICA WEARABLE INJECTOR MARKET SPLIT, BY TYPE (2017)

FIG 22: LATIN AMERICA WEARABLE INJECTOR MARKET SPLIT, BY TECHNOLOGY (2017)

FIG 23: LATIN AMERICA WEARABLE INJECTOR MARKET SPLIT, BY COUNTRY (2017)

FIG 24: EUROPE WEARABLE INJECTOR MARKET SPLIT, BY TYPE (2017)

FIG 25: EUROPE WEARABLE INJECTOR MARKET SPLIT, BY COUNTRY (2017)

FIG 26: APAC WEARABLE INJECTOR MARKET SPLIT, BY TYPE (2017)

FIG 27: APAC WEARABLE INJECTOR MARKET SPLIT, BY APPLICATION (2017)

FIG 28: MEA WEARABLE INJECTOR MARKET SPLIT, BY TYPE (2017)

FIG 29: MEA WEARABLE INJECTOR MARKET SPLIT, BY TECHNOLOGY (2017)

FIG 30: MEA WEARABLE INJECTOR MARKET SPLIT, BY APPLICATION (2017)

FIG 31: MEA WEARABLE INJECTOR MARKET SPLIT, BY END USER (2017)

FIG 32: PORTER’S FIVE FORCES OF COMPETITIVE POSITION ANALYSIS

FIG 33: GLOBAL WEARABLE INJECTORS MARKET SHARE OF KEY PLAYERS, BY PERCENTAGE (2017)

1.   Research Methodology

Wearable Injectors Market Research Methodology
Source: BlueWeave Consulting Analysis

2.   Regional Split of Primary & Secondary Research

Wearable Injectors Market Research Methodology
Source: BlueWeave Consulting Analysis

3.  Secondary Research

The research process began with obtaining historical market sizes of the entire wearable injectors market and the share of each type of segmentation, through exhaustive secondary research to understand the potential of the market under the prevailing market environment during the past years. The growth rate of the market and its segments was studied with a comparative approach to understand the impact of factors that shaped the market during the recent past.

The next step involved the study of present market environment that is influencing the wearable injectors market and its expected long-term impact. Weightage was given to several forces that are expected to affect wearable injectors market, during the forecast period. Based on the interim analysis, the market numbers were formulated for each of the forecast years for every segment.

4.   Primary Research

Various industry experts including CEOs, presidents, vice presidents, directors, sales managers, products managers, organization executives and other key people of the global wearable injectors market were interviewed. The third step involved validation of hypothesis through segmented primary research with the key opinion leaders in the industry, including the company representatives, experts from distributer agencies, service providers and other industry experts. The primary research helped in assessing the gathered and assumed data with the real-time experience of industry representatives. This also led to modification in certain assumptions that were taken during the process of preliminary research. The analysts arrived at solid data points after the completion of primary research process.

In the fourth step, the market engineering was conducted, where the data points collected through secondary and primary sources were compiled to compute the final market sizes.

4.1 Breakdown of Primary Research Respondents, By Industry Participants

Wearable Injectors Market Research Methodology
Source: BlueWeave Consulting Analysis

5.    Market Size Estimation

Top-down approach has been followed to obtain the market size by country. Bottom-Up approach has been followed to obtain market size by type, by technology, by application and by end-users.

An amalgamation of bottom-up and top-down approach has been performed to determine the revenue.

6.   Assumptions for the Study

  • The macro-economic factors would remain same during the forecast period.
  • The market players would exhibit consistent performance during the forecast period without having any adverse ripple effects on the industry.

7.   Market Breakdown & Data Triangulation

Wearable Injectors Market Research Methodology
Source: BlueWeave Consulting Analysis

Related Posts